Our Heart's Mission
Our vision is a thriving, collaborative cardiovascular and stroke research sector that improves lives and delivers lasting health benefits to all Australians.
Where the ACvA Journey Began
In 2015, as funding for cardiovascular disease (CVD) research declined, leading clinician-researchers united to establish the Australian Cardiovascular Alliance (ACvA). Their mission was to secure research investment that more accurately reflected the burden of this leading cause of Australian deaths.
The ACvA leadership recognised that funding alone couldn’t deliver meaningful change - and that addressing the major challenges in CVD requires innovative strategies and a nationally coordinated approach, that includes cross-sector collaboration and engagement.
In 2019, they secured initial funding to set up a small operations team with the remit to build a vibrant and connected CVD research community, united by the goal to reduce CVD in Australia.
Our Vision & Mission
We drive cross-sector collaboration to transform cardiovascular and stroke outcomes. We connect people and expertise to turn evidence into real-world solutions with lasting impact.
Cardiovascular disease (CVD) is the #1 cause of death in Australia and globally.
Every 12 minutes one Australian dies from Cardiovascular disease (CVD).
CVD costs $14.3 billion in expenditure to the Australian health system.
Promote research collaboration to drive innovation and scientific advancement.
Build connections across the sector to unlock new perspectives and drive meaningful progress.
Lead coordinated national efforts to tackle major cardiovascular challenges with bold, system-wide solutions.
Serve as a united voice to influence policy and drive systemic change.
Advocate for continued research investment to maintain our momentum in tackling cardiovascular disease.
Challenge traditional healthcare models and drive innovative approaches.
The Journey So Far: Celebrating Achievements
Over the years, we have made significant strides in improving cardiovascular health in Australia. We are proud of what we have accomplished.
$220M
Over 10 years funding prevention, treatment and recovery from CVD with the MRFF.
$1.3M
Direct funding secured in 2019 for the establishment of a skilled operations team.
$25M
In Tier 1 Grant funding for CVD researchers resulting directly from Clinical Themes Initiative outputs.
Secured ongoing operational funding from NSW, TAS, NT and Federal Govts.
Snow Medical Research Foundation funding recipient
Established the National Hypertension Taskforce alongside Hypertension Australia
Creation of the Cardiovascular Health Research Leadership Forum (CV HLRF)
Establishment of annual Excellence in Cardiovascular Research Awards in 2021
Defining Success In The Future
In the future ACvA will be a national leader that embeds research, data, and innovation into healthcare policy and delivery. We will serve as a hub for long-term, impact-driven programs that address major challenges in cardiovascular disease.
As a strong advocate for the research sector, ACvA will champion strategic investment, research translation, and the vital role of discovery in improving health outcomes.
Underpinning this will be a sustainable and resilient foundation, with strong core operations, diverse funding streams, robust partnerships, and a thriving connected community.
By partnering with us, you’ll help deliver groundbreaking solutions that improve heart health, prevent disease, and transform lives.
Together, we can create a legacy of longer, stronger, healthier lives for all.
Join Us in Making a Difference
Join our communityYour support can transform lives and enhance health initiatives in our community.